BioSpace News Archive

Celsion Corporation (NASDAQ: CLSN), a clinical-stage company focused on DNA-based immunotherapy and next-generation vaccines, today announced the appointment of Stacy R. Lindborg, Ph.D. to its Board of Directors, effective June 4, 2021.

Dr. Pepose is Recognized as an Esteemed Key Opinion Leader in Ophthalmology with Nearly 40 Years of Experience as a Leading Clinical Researcher and Treating Physician

Outlook Therapeutics, reported today that it has administered the final dose to the last patient enrolled in its pivotal NORSE TWO safety and efficacy study evaluating ONS-5010 for treatment of wet age-related macular degeneration.

GT Biopharma, Inc. announced that it is set to be added to the Russell 2000® Index at the conclusion of the Russell US Indexes annual reconstitution, effective at the opening of the U.S. equity markets on June 28, 2021.

Phase 3 efficacy trial planned to commence this summer in areas of the world underserved by vaccines.

Embolx Inc., a medical device company manufacturing advanced microcatheters for arterial embolization procedures announced a limited release of its balloon occlusion microcatheter, Sniper®, in the European market.

CARISMA Therapeutics Inc. announced today that Richard Morris has been appointed Chief Financial Officer (CFO).

Alira Health (www.alirahealth.com), a leading international healthcare and life sciences advisory services firm, announced that it has acquired CROS NT (www.crosnt.com), a data-driven Contract Research Organization (CRO) headquartered in Italy with offices across Europe and the United States.

Q2 Solutions, a wholly-owned subsidiary of IQVIA and a leading clinical trial laboratory services organization, today announced a transformative collaboration with Tasso Inc., a pioneer in clinical-grade, at-home, patient-centered blood testing, to develop diagnostic tests used in decentralized (virtual) clinical trials.

PanTheryx, the world’s largest colostrum-based nutrition and biotechnology company, announced the publication of a new scientific paper titled, “Colostrum therapy for human gastrointestinal health and disease” in the peer-reviewed journal Nutrients.